Oct 2015

Substandard drugs cheaper than generics they copy: peer review findings - Roger Bate

The Journal of Economics and Management Strategy has published our paper (Link), the first to statistically prove that substandard medicines are cheaper than the generics they copy. This is useful since it means that regulators (especially in emerging markets) can target more precisely the parts of the market likely to exhibit such problems. As predicted fake products are passed off at nearly identical pricing to the generics they copy, so market signals are not helpful in finding fakes.
Read More…

Substandard TB drugs probably accelerating resistance - Roger Bate

The World Health Organization released details today that tuberculosis now kills more than HIV/AIDS – approximately one and half million people every year. And the largest worry is that drug resistance versions of medicines to treat TB are becoming more common and deadly. This is a major risk for emerging nations and a costly one for richer nations, where quarantining patients is incredibly expensive.
Read More…
© 2014 Safe Medicines Coalition Contact Us